期刊文献+

来氟米特凝胶剂的制备与质量控制 被引量:1

Preparation and Quality Control of Leflunomide Chitosan Gel
下载PDF
导出
摘要 目的制备来氟米特凝胶剂,并建立其质量控制方法。方法以壳聚糖为凝胶材料制备来氟米特凝胶剂,采用高效液相色谱法测定来氟米特含量。结果来氟米特质量浓度在10~100μg/mL范围内与峰面积线性关系良好,平均回收率为100.3%,RSD为0.67%(n=6)。结论制备工艺合理、简单,含量测定方法可行,制剂质量稳定。 Objective To study the preparation and quality control method of Leflunomide Chitosan Gel. Methods Chitosan as gel material was used to prepare Leflunomide Chitosan Gel. The content of leflunomide was determined by HPLC. Results The linear range was 10- 100 μg/mL of leflunomide,the average recovery rate was 100. 3% ,and RSD =0, 67% (n = 6). Conclusion The preparing method is easy, while the assaying method is reliable,the quality of Leflunomide Chitosan Gel is stable.
出处 《中国药业》 CAS 2008年第13期38-39,共2页 China Pharmaceuticals
关键词 来氟米特 壳聚糖 凝胶剂 质量控制 leflunomide chitosan gel quality control
  • 相关文献

参考文献5

二级参考文献14

  • 1吴葆杰.现代临床治疗药物大全[M].北京:中国医药科技出版社,1995.819.
  • 2Kalden J R,Schattenkirchner M,Sorensen H,et al.The efficacy and safety of leflunomide in patients with active rheumatoid arthritis: a five-year followup study[J].Arthritis Rheum,2003,48 (6): 1513.
  • 3Siva C,Eisen S A,Shepherd R,et al.Leflunomide use during the first 33 months after food and drug administration approval: experience with a national cohort of 3,325 patients[J].Arthritis Rheum,2003,49(6): 745.
  • 4Li J,Yao H W,Jin Y,et al.Pharmacokinetics of leflunomide in Chinese healthy volunteers[J].Acta Pharmacol Sin,2002,23(6): 551.
  • 5Schmidt A,Schwind B,Gillich M,et al.Simultaneous determination of leflunomide and its active metabolite,A77 1726,in human plasma by high-performance liquid chromatography[J].Biomed Chromatogr,2003,17(4): 276.
  • 6Smolen J S,Kalden J R,Scott D R,et al.Efficacy and safety of leffunomide compared with placebo and sulphasalazine in active rheumatoid arthritis:a double-blind,randomized,multicentre treal.European Lefiunomide Study Group[J].Lancet,1999,353 (9194):259-266.
  • 7Rozman B.Clinic experience with leffunomide in rheumatoid arthritis[J].J Rheumatol,1998,53 (Suppl):27-32.
  • 8Miadenovic V.Safety and effectiveness of lefLunomide in the treatment of patients with active rheumatoid arthritis[J].Arthritis Rheum,1995,38 (11):1595-1603.
  • 9Fox R I.Mechanism of action of leffunomide in rheumatoid arthritis[J].J Rheumatol,1998,53 (Suppl):20-26.
  • 10Silva Junior H T,Morris R E.Leflunomide and malononitrelamides[J].Am J Med Sci,1997,313 (5):289-301.

共引文献20

同被引文献9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部